Investment List

44 investments found

Date	Investor	Investor*	Target	Round	Group	Amount (USD)	Country
2022-12-30	OrbiMed	OrbiMed	Stairway Medical	Series A	3 Early Growth	—
2022-12-29	OrbiMed	OrbiMed	ArriVent Biopharma	Series B	3 Early Growth	—
2022-12-07	OrbiMed	OrbiMed	Apogee Therapeutics	Series B	3 Early Growth	—
2022-11-30	OrbiMed	OrbiMed	iECURE	Series A	3 Early Growth	—
2022-11-14	OrbiMed	OrbiMed	MBX Biosciences	Series B	3 Early Growth	—
2022-11-10	OrbiMed	OrbiMed	Alpheus Medical	Series A	3 Early Growth	—
2022-11-07	OrbiMed	OrbiMed	Pulnovo Medical	Venture Round	7 Other	—
2022-11-02	OrbiMed	OrbiMed	Compass Therapeutics, Inc.	Post-IPO Equity	6 Exit / Public	—
2022-11-02	OrbiMed	OrbiMed	Alterome Therapeutics	Series A	3 Early Growth	—
2022-10-19	OrbiMed	OrbiMed	PIC Therapeutics	Series A	3 Early Growth	—
2022-10-19	OrbiMed	OrbiMed	Insmed	Post-IPO Debt	6 Exit / Public	—
2022-10-13	OrbiMed	OrbiMed	Odyssey Therapeutics	Series B	3 Early Growth	—
2022-10-13	OrbiMed	OrbiMed	VectivBio	Post-IPO Equity	6 Exit / Public	—
2022-10-11	OrbiMed	OrbiMed	Treeline Biosciences	Series A	3 Early Growth	—
2022-09-14	OrbiMed	OrbiMed	Capstan Therapeutics	Series A	3 Early Growth	—
2022-09-13	OrbiMed	OrbiMed	ACELYRIN	Series C	4 Growth	—
2022-09-12	OrbiMed	OrbiMed	Adaptive Biotechnologies	Post-IPO Debt	6 Exit / Public	—
2022-09-01	OrbiMed	OrbiMed	Kapiva	Series C	4 Growth	—
2022-08-10	OrbiMed	OrbiMed	Disc Medicine	Post-IPO Equity	6 Exit / Public	—
2022-07-18	OrbiMed	OrbiMed	Delfi Diagnostics	Series B	3 Early Growth	—
2022-07-11	OrbiMed	OrbiMed	LifeWell	Venture Round	7 Other	—
2022-06-30	OrbiMed	OrbiMed	X4 Pharmaceuticals	Post-IPO Equity	6 Exit / Public	—
2022-06-29	OrbiMed	OrbiMed	MiroBio	Series B	3 Early Growth	—
2022-06-24	OrbiMed	OrbiMed	Frontera Therapeutics	Series B	3 Early Growth	—
2022-06-16	OrbiMed	OrbiMed	Aerin Medical	Private Equity Round	7 Other	—
2022-06-09	OrbiMed	OrbiMed	CHARM Therapeutics	Series A	3 Early Growth	—
2022-06-09	OrbiMed	OrbiMed	DarioHealth	Post-IPO Debt	6 Exit / Public	—
2022-06-02	OrbiMed	OrbiMed	Upstream Bio	Series A	3 Early Growth	—
2022-05-25	OrbiMed	OrbiMed	Terremoto Biosciences	Series A	3 Early Growth	—
2022-05-09	OrbiMed	OrbiMed	Aspen Neuroscience	Series B	3 Early Growth	—
2022-04-26	OrbiMed	OrbiMed	Valneva	Post-IPO Debt	6 Exit / Public	—
2022-04-19	OrbiMed	OrbiMed	Sionna Therapeutics	Series B	3 Early Growth	—
2022-03-17	OrbiMed	OrbiMed	Harvest Integrated Research Organization	Series A	3 Early Growth	—
2022-03-01	OrbiMed	OrbiMed	MDClone	Series C	4 Growth	—
2022-02-16	OrbiMed	OrbiMed	Star Therapeutics	Venture Round	7 Other	—
2022-02-16	OrbiMed	OrbiMed	Electra Therapeutics	Series B	3 Early Growth	—
2022-02-15	OrbiMed	OrbiMed	ArriVent Biopharma	Series A	3 Early Growth	—
2022-02-08	OrbiMed	OrbiMed	Congruence Therapeutics	Series A	3 Early Growth	—
2022-01-28	OrbiMed	OrbiMed	HanBio Therapeutics	Series A	3 Early Growth	—
2022-01-20	OrbiMed	OrbiMed	ImmPACT Bio	Series B	3 Early Growth	—
2022-01-19	OrbiMed	OrbiMed	Alterome Therapeutics	Series A	3 Early Growth	—
2022-01-05	OrbiMed	OrbiMed	Nucleix	Venture Round	7 Other	—
2022-01-01	OrbiMed	OrbiMed	Beijing Tianxing	Series B	3 Early Growth	—
2022-01-01	OrbiMed	OrbiMed	Leal Therapeutics	Seed Round	2 Seed	—